Wire Stories
-
625Canterbury Park Holding Corporation Reports Record 2021 Third Quarter Results
SHAKOPEE, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) — Canterbury Park Holding Corporation (�Canterbury� or the �Company�) (NASDAQ: CPHC), today reported record financial...
-
663Proactive news headlines including Tesla, MGX Minerals, Bragg Gaming, Clean Air Metals, Harbor Custom Development and CytoDyn
New York , Nov. 08, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in...
-
578Qurient Announces Collaboration Agreement with MSD to Evaluate Selective Triple Inhibitor Q702 in Combination With KEYTRUDA� (pembrolizumab)
– Q702 is a novel, orally available triple kinase inhibitor that selectively targets Axl, Mer, and CSF1R – A phase 1 study...
-
530
RMIT Turns to HPE GreenLake to Increase Agility and Adapt to Dynamic Education and Research Opportunities
RMIT University adopts HPE GreenLake to meet increasing demand for online learning and growth of its essential research HPE GreenLake eliminates heavy...
-
519Studio City International Holdings Limited Announces Unaudited Third Quarter 2021 Earnings
MACAU, Nov. 09, 2021 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (�Studio City� or the �Company�), a world-class integrated...
-
654Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
— Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China — — Collaboration accelerates and expands...
-
660BIO-key adds Cyber Threat Intelligence Services, Cyberlitica to Channel Alliance Partner Program, Helping Customers Address Core Aspects of a Holistic Cybersecurity Program
WALL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM)...
-
552Gilat Reports Strong Revenue & Profitability Growth in Third Quarter 2021
Revenue up 34% year-over-year to $49.9M, GAAP operating income of $0.9 million and Adjusted EBITDA reached $4.0 million PETAH TIKVA, Israel, Nov....
-
650Zai Lab and Karuna Therapeutics Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
Zai Lab obtains exclusive rights to develop and commercialize KarXT in Greater China Karuna to receive upfront cash payment of $35 million,...
-
666Zai Lab Announces Third Quarter 2021�Financial Results and Corporate Updates
— Broad Product Pipeline Expands Both Vertically and Horizontally with Three New Potential First-in-Class or Best-in-Class Medicines — Company to Host Conference...
